L-tryptophan produced a moderate increase in kynurenine output in the control subjects and a large increase in output in the majority of patients with rheumatoid arthritis.
This was the most striking difference between the two groups. The effect of pyridoxine administration on this test (Kynurenine excretion after L-tryptophan) was subsequently studied in a group of patients suffering from rheumatoid arthritis. McKusick and Hsu (1961) in a recent study reported the effect of pyridoxine administration on a syndrome of tendinitis, joint tenderness and pain developed by a group of patients suffering from tuberculosis treated with isoniazid, a known pyridoxine inhibitor. Pyridoxine administration caused reduction in pain, 43 but there appeared to be an optimal dosage beyond which further increase in stiffness occurred. In the present study the abnormally high kynurenine excretion in ten out of eleven rheumatoid patients was reduced by the administration of pyridoxine.
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McKusick, A. B., and Hsu, J. M. (1961) . This preliminary report concerns the investigation of two cases of skeletal muscle glycogenosis due to different enzyme defects. One occurred in a 48 years old man and the other in a four years old boy, and each presented a different clinical appearance.
The adult had a life-long history of painful muscle cramps and weakness only on continued exertion, while his muscle power and bulk remained normal. The child showed very slight generalised muscle weakness and wasting, but had no cramps on exertion; his gastrocnemii, however, were firm, bulky, and contracted so that he had to walk on his toes. Neither patient gave a history of myoglobinuria, nor was this found on urine spectroscopy. Electromyography showed a myopathic pattern in the child, but was normal in the adult.
Serum enzyme assay in both patients, however, showed moderate but not gross elevation of the activities of aldolase, GO-T, GP-T and creatine phosphokinase consistent with the presence of myopathy. Histology of muscle biopsy specimens from each gave no evidence of muscular dystrophy on staining with haematoxylin and eosin, but instead showed many sarcoplasmic and sub-sarcolemmal vacuoles; on staining directly for glycogen with periodic acid-Schiff these vacuoles were seen to be filled with deeplystaining material. Chemical determination of the glycogen content of biopsy specimens showed it to be greatly increased in both cases compared with the content of normal muscle specimens. Analysis of the glycogen isolated from the muscle of each patient showed its structure to be normal and quite different from that of phosphorylase limit dextrin or amylopectin.
Lactic acid production by both patients during ischaemic exercise was studied by assay of serial blood specimens taken from the arm veins after squeezing a bulb in the hand while the arm and wrist were occluded by sphygmomanometer cuffs. A healthy subject showed the expected steep rise in blood lactic acid, while the child showed only a slight rise and the adult no rise at all. These findings indicated defective muscle glycolysis in both patients. The phosphorylase activity of muscle homogenates was then determined by liberation of inorganic phosphate from added G-l-P in the presence of NaF, adenylic acid and glycogen starter. The muscle of the child showed rather less phosphorylase activity than a normal control specimen, but the adult muscle showed complete absence of phosphorylase activity. Suitably supplemented and buffered homogenates of muscle from both patients were then incubated in anaerobic conditions with glycogen, G-I-P, G-6-P and FDP, and the lactic acid produced estimated after precipitation of protein by trichloracetic acid. The absence of phosphorylase activity in the adult was confirmed by the failure of his muscle homogenate to produce lactic acid from added glycogen, while the production of normal amounts from the other substrates demonstrated intact glycolysis subsequent to phosphorylase. By the same evidence, the muscle of the child, in which phosphorylase activity was already known to be somewhat diminished, now showed the presence of other enzyme deficiencies after the stage of FDP, in addition to a severe, but not absolute, deficiency of phosphoglucomutase.
That this latter deficiency need not be lethal is confirmed by the recent identification in tissues by Hers (1961) and Rosenfeld (1961) of the hydrolytic enzyme amyloglucosidase, by which means glycogen may be degraded to free glucose for admission to the glycolytic pathway as G-6-P after the stage of phosphoglucomutase.
Skeletal muscle glycogenosis in adults due to complete absence of muscle phosphorylase has been described previously on two occasions by Schmid and Mahler (1959) and by Pearson, Rimer and Mommaerts (1961) . A comparable condition in children due to several partial defects in skeletal muscle glycolysis has not yet been described, though di Sant'Agnese (1959) recorded similar clinical appearances in a child whose skeletal muscle showed a greatly increased glycogen content. No systematic investigation was carried out, however, in that patient.
